CP and hemolysis: Specifically targeting the AP in PNH and aHUS may be beneficial since it accounts for approximately 80% of the terminal pathway activity (90, 91) and may prevent both extravascular and intravascular hemolysis in PNH while preserving many of the functions of the CP and lectin pathway (LP).